within Pharmacolibrary.Drugs.S_SensoryOrgans.S01G_DecongestantsAndAntiallergics.S01GA07_Brimonidine;
model Brimonidine 
   extends Pharmacolibrary.Drugs.ATC.S.S01GA07;

  annotation(Documentation(
    info ="<html><body><p>Brimonidine is an alpha-2 adrenergic receptor agonist used primarily in ophthalmology to reduce intraocular pressure in patients with open-angle glaucoma or ocular hypertension. It is administered as an ophthalmic solution and is an approved and currently used drug.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in adults following topical ocular administration under steady-state conditions.</p><h4>References</h4><ol><li><p>Xiang, A, et al., &amp; Zhong, X (2023). Ocular Posterior Segment Distribution and Pharmacokinetics of Brimonidine After Intravitreal Administration in Guinea Pigs. <i>Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics</i> 39(7) 456–462. DOI:<a href=&quot;https://doi.org/10.1089/jop.2023.0020&quot;>10.1089/jop.2023.0020</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/37311153/&quot;>https://pubmed.ncbi.nlm.nih.gov/37311153</a></p></li><li><p>Tanihara, H, et al., &amp; Suganami, H (2023). Crossover Randomized Study of Pharmacologic Effects of Ripasudil-Brimonidine Fixed-Dose Combination Versus Ripasudil or Brimonidine. <i>Advances in therapy</i> 40(8) 3559–3573. DOI:<a href=&quot;https://doi.org/10.1007/s12325-023-02534-w&quot;>10.1007/s12325-023-02534-w</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/37330927/&quot;>https://pubmed.ncbi.nlm.nih.gov/37330927</a></p></li><li><p>Tamhane, M, et al., &amp; Attar, M (2021). Ocular Pharmacokinetics of Brimonidine Drug Delivery System in Monkeys and Translational Modeling for Selection of Dose and Frequency in Clinical Trials. <i>The Journal of pharmacology and experimental therapeutics</i> 378(3) 207–214. DOI:<a href=&quot;https://doi.org/10.1124/jpet.120.000483&quot;>10.1124/jpet.120.000483</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/34210753/&quot;>https://pubmed.ncbi.nlm.nih.gov/34210753</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Brimonidine;
